Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
(NY:
ALUR
)
0.6825
+0.0425 (+6.64%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about ALUR
< Previous
1
2
Next >
Allurion Announces the Appointment of Adrian Wild as Senior Vice President, International Commercial
August 20, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Receives Continued Listing Standards Notice from NYSE
August 15, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Reports Second Quarter 2024 Financial Results and Provides Business Update
August 13, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion to Report Second Quarter 2024 Financial Results on August 13, 2024
July 16, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Announces Pricing of $20 million Public Offering and Concurrent Private Placement
June 28, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Announces Launch of Offering of Common Stock and Warrants
June 26, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Announces Publication of New Data Demonstrating Lean Mass Gains in Patients Experiencing 14% Weight Loss
June 20, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Announces Three Scientific Presentations at the 40th Annual Meeting of the American Society for Metabolic and Bariatric Surgery
June 11, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Announces the Appointment of Ojas A. Buch as Chief Operating Officer
June 05, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Announces Expansion of AI Weight Loss Coach to Support Patients on GLP-1s
May 30, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion to Participate in Two Upcoming Investor Conferences in June 2024
May 29, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Announces Three Scientific Presentations at the European Congress on Obesity, Including Study on Lean Mass Preservation for Sustainable, Healthy Weight Loss
May 15, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Reports First Quarter 2024 Financial Results and Provides Business Update
May 14, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Announces Three Scientific Presentations at IFSO-European Chapter 2024, Including First-Ever 3-Year Weight Maintenance Survey
May 02, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Announces Preliminary First Quarter 2024 Results
April 30, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Closes $48 Million Convertible Senior Secured Note Financing with RTW Investments
April 17, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Expands Virtual Care Suite to the United States
April 04, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance
March 21, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
March 13, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Milena Alberti-Perez Joins Allurion Board of Directors as Audit Committee Chair
March 12, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion to Report Fourth Quarter 2023 Financial Results on March 21, 2024
March 04, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion to Participate in Cowen’s 44th Annual Health Care Conference
February 20, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference
February 08, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Brendan Gibbons Appointed Chief Legal Officer at Allurion Technologies
January 29, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Somerset NHS Foundation Trust Treats First Patients with Allurion Balloon for Pre-Surgical Weight Loss
January 23, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion's Virtual Care Suite Digital Platform Accelerates Commercial Expansion With New Strategic Partnerships
January 17, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Announces Publication of Randomized, Double-Blind Study Demonstrating Significant Improvement in Obesity-Related Co-Morbidities
January 11, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Announces Preliminary Fourth Quarter and Full Year 2023 Results and Provides 2024 Outlook
January 08, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
New research highlights the positive impact of GLP-1s and other anti-obesity medications on the Allurion Program
January 05, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion’s Digital Platform Gains Traction with Expanded Strategic Partnership
January 02, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.